SEC Form RW filed by Atlantic International Corp.
$ATLN
Biotechnology: Laboratory Analytical Instruments
Industrials
May 12, 2026
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: | Atlantic International Corp. | |||||||
Request to Withdraw Registration Statement on Form S-3 SEC File No. 333-294523 | ||||||||
Ladies and Gentlemen,
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Atlantic International Corp. (the “Company”) respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s Registration Statement on Form S-3 (Registration No. 333-294523), together with all exhibits and amendments thereto (the “Registration Statement”). The Registration Statement has not been declared effective, and no securities of the Company were sold in connection with the offering.
The Company respectfully requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the account of the Company for future use.
Should you have any questions regarding the withdrawal, please contact the Company’s legal counsel, Elliot H. Lutzker, Esq. at (646) 428-3210.
Thank you for your assistance in this matter.
Sincerely,
Atlantic International Corp.
/s/ Jeffrey Jagid | |||||
By: Jeffrey Jagid | |||||
Title: Chief Executive Officer | |||||